Published in Nat Rev Nephrol on January 10, 2012
An US Mathematical Model in Predicting Renal Transplant Rejection | NCT03045731
Urinary-cell mRNA profile and acute cellular rejection in kidney allografts. N Engl J Med (2013) 7.40
MicroRNAs as biomarkers in solid organ transplantation. Am J Transplant (2012) 0.99
Urinary cell mRNA profiles and differential diagnosis of acute kidney graft dysfunction. J Am Soc Nephrol (2014) 0.90
Proteomics and metabolomics in renal transplantation-quo vadis? Transpl Int (2012) 0.85
A label-free approach by infrared spectroscopic imaging for interrogating the biochemistry of diabetic nephropathy progression. Kidney Int (2016) 0.82
Profiling circulating microRNA expression in a mouse model of nerve allotransplantation. J Biomed Sci (2013) 0.80
Early posttransplant changes in circulating endothelial microparticles in patients with kidney transplantation. Transpl Immunol (2014) 0.79
Circulating Organ-Specific MicroRNAs Serve as Biomarkers in Organ-Specific Diseases: Implications for Organ Allo- and Xeno-Transplantation. Int J Mol Sci (2016) 0.77
Genomic and proteomic fingerprints of acute rejection in peripheral blood and urine. Transplant Rev (Orlando) (2014) 0.76
Identification of Circulating miRNAs in a Mouse Model of Nerve Allograft Transplantation under FK506 Immunosuppression by Illumina Small RNA Deep Sequencing. Dis Markers (2015) 0.75
Non-invasive approaches in the diagnosis of acute rejection in kidney transplant recipients, part II: omics analyses of urine and blood samples. Clin Kidney J (2016) 0.75
Non-invasive approaches in the diagnosis of acute rejection in kidney transplant recipients. Part I. In vivo imaging methods. Clin Kidney J (2016) 0.75
Active haemorrhage of a renal allograft detected on portable ultrasound. BMJ Case Rep (2013) 0.75
Both absolute and relative quantification of urinary mRNA are useful for non-invasive diagnosis of acute kidney allograft rejection. PLoS One (2017) 0.75
M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med (2009) 11.81
The natural history of chronic allograft nephropathy. N Engl J Med (2003) 8.70
Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant (2008) 8.09
Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat Med (2011) 6.35
Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant (2007) 5.39
Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med (2002) 5.34
Long-term outcome of renal transplantation from older donors. N Engl J Med (2006) 5.10
Messenger RNA for FOXP3 in the urine of renal-allograft recipients. N Engl J Med (2005) 5.02
Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. N Engl J Med (2003) 4.35
Long-term renal allograft survival in the United States: a critical reappraisal. Am J Transplant (2010) 4.09
The APOL1 gene and allograft survival after kidney transplantation. Am J Transplant (2011) 3.69
Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure. Am J Transplant (2009) 3.43
Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: a contribution of humoral immunity to chronic allograft rejection. J Am Soc Nephrol (2002) 3.34
Anti-phospholipase A2 receptor antibody in membranous nephropathy. J Am Soc Nephrol (2011) 3.05
C4d and C3d staining in biopsies of ABO- and HLA-incompatible renal allografts: correlation with histologic findings. Am J Transplant (2006) 2.81
Identifying specific causes of kidney allograft loss. Am J Transplant (2008) 2.77
Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure. Transplantation (2010) 2.59
Risk of renal allograft loss from recurrent glomerulonephritis. N Engl J Med (2002) 2.54
Morphometric and visual evaluation of fibrosis in renal biopsies. J Am Soc Nephrol (2010) 2.32
Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining. Am J Transplant (2009) 2.27
Microarray analysis of rejection in human kidney transplants using pathogenesis-based transcript sets. Am J Transplant (2007) 2.25
A novel pathway of chronic allograft rejection mediated by NK cells and alloantibody. Am J Transplant (2011) 2.16
Fibrosis with inflammation at one year predicts transplant functional decline. J Am Soc Nephrol (2010) 2.09
FOXP3 expression in human kidney transplant biopsies is associated with rejection and time post transplant but not with favorable outcomes. Am J Transplant (2008) 1.94
Specificity of histological markers of long-term CNI nephrotoxicity in kidney-transplant recipients under low-dose cyclosporine therapy. Am J Transplant (2011) 1.77
Overlapping pathways to transplant glomerulopathy: chronic humoral rejection, hepatitis C infection, and thrombotic microangiopathy. Kidney Int (2011) 1.73
Chronic humoral rejection: identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries. J Am Soc Nephrol (2001) 1.72
Pathological and clinical correlates of FOXP3+ cells in renal allografts during acute rejection. Am J Transplant (2007) 1.67
Significance of C4d Banff scores in early protocol biopsies of kidney transplant recipients with preformed donor-specific antibodies (DSA). Am J Transplant (2011) 1.66
A mouse model for polyomavirus-associated nephropathy of kidney transplants. Am J Transplant (2006) 1.65
NK cell transcripts and NK cells in kidney biopsies from patients with donor-specific antibodies: evidence for NK cell involvement in antibody-mediated rejection. Am J Transplant (2010) 1.62
Polyomavirus BK versus JC replication and nephropathy in renal transplant recipients: a prospective evaluation. Transplantation (2007) 1.56
The Maryland aggregate pathology index: a deceased donor kidney biopsy scoring system for predicting graft failure. Am J Transplant (2008) 1.48
Thrombotic microangiopathy after kidney transplantation. Am J Transplant (2010) 1.44
C4d staining of renal allograft biopsies: a comparative analysis of different staining techniques. Nephrol Dial Transplant (2006) 1.40
Acute renal endothelial injury during marrow recovery in a cohort of combined kidney and bone marrow allografts. Am J Transplant (2011) 1.38
Incidence of C4d stain in protocol biopsies from renal allografts: results from a multicenter trial. Am J Transplant (2005) 1.37
BK virus infection in transplant recipients: an overview and update. Am J Transplant (2006) 1.30
Detection of the complement degradation product C4d in renal allografts: diagnostic and therapeutic implications. J Am Soc Nephrol (2002) 1.30
Recurrent and de novo glomerular disease after renal transplantation: a report from Renal Allograft Disease Registry (RADR). Transplantation (1999) 1.27
Complement independent antibody-mediated endarteritis and transplant arteriopathy in mice. Am J Transplant (2010) 1.23
Effect of antibodies on endothelium. Am J Transplant (2009) 1.23
Early acceptance of renal allografts in mice is dependent on foxp3(+) cells. Am J Pathol (2011) 1.23
Protocol biopsies in renal transplantation: prognostic value of structural monitoring. Kidney Int (2007) 1.17
Expression of complement components differs between kidney allografts from living and deceased donors. J Am Soc Nephrol (2009) 1.16
Presence of FoxP3+ regulatory T Cells predicts outcome of subclinical rejection of renal allografts. J Am Soc Nephrol (2008) 1.15
The transcriptome of the implant biopsy identifies donor kidneys at increased risk of delayed graft function. Am J Transplant (2007) 1.13
Four stages and lack of stable accommodation in chronic alloantibody-mediated renal allograft rejection in Cynomolgus monkeys. Am J Transplant (2008) 1.11
Combination of peritubular c4d and transplant glomerulopathy predicts late renal allograft failure. J Am Soc Nephrol (2009) 1.11
Tubular expression of KIM-1 does not predict delayed function after transplantation. J Am Soc Nephrol (2009) 1.10
Histopathologic clusters differentiate subgroups within the nonspecific diagnoses of CAN or CR: preliminary data from the DeKAF study. Am J Transplant (2009) 1.10
SWOT analysis of Banff: strengths, weaknesses, opportunities and threats of the international Banff consensus process and classification system for renal allograft pathology. Am J Transplant (2007) 1.10
C4d-negative antibody-mediated rejection in renal allografts: evidence for its existence and effect on graft survival. Clin Nephrol (2011) 1.09
Achieving donor-specific hyporesponsiveness is associated with FOXP3+ regulatory T cell recruitment in human renal allograft infiltrates. J Immunol (2007) 1.08
Donor-specific antibodies accelerate arteriosclerosis after kidney transplantation. J Am Soc Nephrol (2011) 1.07
Chronic calcineurin inhibitor nephrotoxicity-lest we forget. Am J Transplant (2011) 1.06
De novo collapsing glomerulopathy in renal allografts. Transplantation (1998) 1.05
Regulatory, effector, and cytotoxic T cell profiles in long-term kidney transplant patients. J Am Soc Nephrol (2009) 1.05
Improving distribution efficiency of hard-to-place deceased donor kidneys: Predicting probability of discard or delay. Am J Transplant (2010) 1.04
Presence of urinary Haufen accurately predicts polyomavirus nephropathy. J Am Soc Nephrol (2009) 1.03
Interobserver agreement for Polyomavirus nephropathy grading in renal allografts using the working proposal from the 10th Banff Conference on Allograft Pathology. Hum Pathol (2011) 0.99
Chronic allograft nephropathy. N Engl J Med (2003) 0.99
Longitudinal analysis of chronic allograft nephropathy: clinicopathologic correlations. Kidney Int Suppl (2005) 0.99
De novo thrombotic microangiopathy in renal allograft biopsies-role of antibody-mediated rejection. Am J Transplant (2010) 0.98
Cluster analysis of lesions in nonselected kidney transplant biopsies: microcirculation changes, tubulointerstitial inflammation and scarring. Am J Transplant (2010) 0.98
Incidence, predictors and outcomes of transplant renal artery stenosis after kidney transplantation: analysis of USRDS. Am J Nephrol (2009) 0.97
Interstitial fibrosis quantification in renal transplant recipients randomized to continue cyclosporine or convert to sirolimus. Am J Transplant (2009) 0.97
Predominant Th1 and cytotoxic phenotype in biopsies from renal transplant recipients with transplant glomerulopathy. Am J Transplant (2009) 0.96
Protocol biopsies in renal transplantation: insights into patient management and pathogenesis. Am J Transplant (2007) 0.96
Influence of African-American ethnicity on acute rejection after early steroid withdrawal in primary kidney transplant recipients. Transplant Proc (2010) 0.95
Expression of B cell and immunoglobulin transcripts is a feature of inflammation in late allografts. Am J Transplant (2008) 0.95
Subclinical rejection in stable positive crossmatch kidney transplant patients: incidence and correlations. Am J Transplant (2009) 0.94
Allograft failure in kidney transplant recipients with membranoproliferative glomerulonephritis. Am J Kidney Dis (2011) 0.94
Adding value to liver (and allograft) biopsy evaluation using a combination of multiplex quantum dot immunostaining, high-resolution whole-slide digital imaging, and automated image analysis. Clin Liver Dis (2010) 0.94
Histogenomics: association of gene expression patterns with histological parameters in kidney biopsies. Transplantation (2009) 0.93
Gene-expression profiles and age of donor kidney biopsies obtained before transplantation distinguish medium term graft function. Transplantation (2007) 0.93
The molecular phenotype of kidney transplants. Am J Transplant (2010) 0.92
The clinical usefulness of the renal allograft biopsy in the cyclosporine era: a prospective study. Transplantation (1999) 0.89
Tubular basement membrane immune deposits in association with BK polyomavirus nephropathy. Am J Transplant (2007) 0.88
Reproducibility studies on arteriolar hyaline thickening scoring in calcineurin inhibitor-treated renal allograft recipients. Am J Transplant (2006) 0.88
The regulatory/cytotoxic graft-infiltrating T cells differentiate renal allograft borderline change from acute rejection. Transplantation (2007) 0.87
Intragraft FOXP3 protein or mRNA during acute renal allograft rejection correlates with inflammation, fibrosis, and poor renal outcome. Transplantation (2009) 0.86
Cytokine gene expression in kidney allograft biopsies after donor brain death and ischemia-reperfusion injury using in situ reverse-transcription polymerase chain reaction analysis. Transplantation (2007) 0.86
Laparoscopic donor nephrectomy gene expression profiling reveals upregulation of stress and ischemia associated genes compared to control kidneys. Transplantation (2005) 0.86
Antibody-mediated rejection following transplantation from an HLA-identical sibling. Nephrol Dial Transplant (2009) 0.85
Adenovirus interstitial nephritis and rejection in an allograft. J Am Soc Nephrol (2011) 0.85
Putative antibody-mediated rejection with C4d deposition in HLA-identical, ABO-compatible renal allografts. Transplant Proc (2006) 0.84
Polyomavirus-associated nephropathy risk in kidney transplants: the influence of recipient age and donor gender. Kidney Int (2007) 0.83
Intragraft expression of the IL-10 gene is up-regulated in renal protocol biopsies with early interstitial fibrosis, tubular atrophy, and subclinical rejection. Am J Pathol (2010) 0.82
Intragraft levels of Foxp3 mRNA predict progression in renal transplants with borderline change. J Am Soc Nephrol (2008) 0.82
High transforming growth factor-beta and extracellular matrix mRNA response in renal allografts during early acute rejection is associated with absence of chronic rejection. Transplantation (2002) 0.81
Pathology: donor biopsy evaluation at time of renal grafting. Nat Rev Nephrol (2009) 0.80
Gamma-interferon gene expression in human renal allograft fine-needle aspirates. Transplantation (1994) 0.80
Early onset adenovirus infection after simultaneous kidney-pancreas transplant. Am J Transplant (2011) 0.79
Hypertension following kidney transplantation. Adv Chronic Kidney Dis (2011) 0.78
Distinctive gene expression profiles characterize donor biopsies from HCV-positive kidney donors. Transplantation (2010) 0.77
Collapsing glomerulopathy in a renal transplant recipient: potential molecular mechanisms. Ann Transplant (2011) 0.77
HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med (2008) 7.42
Strategies to improve long-term outcomes after renal transplantation. N Engl J Med (2002) 6.76
Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection. Am J Transplant (2003) 4.54
Campath-1H induction plus rapamycin monotherapy for renal transplantation: results of a pilot study. Am J Transplant (2003) 2.83
Case records of the Massachusetts General Hospital. Case 31-2007. A 41-year-old man with abdominal pain and elevated serum creatinine. N Engl J Med (2007) 2.71
Case records of the Massachusetts General Hospital. Case 23-2010. A 49-year-old man with erythrocytosis, perinephric fluid collections, and renal failure. N Engl J Med (2010) 2.62
Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation. Transplantation (2013) 2.55
CD154 blockade for induction of mixed chimerism and prolonged renal allograft survival in nonhuman primates. Am J Transplant (2004) 2.45
Morphometric and visual evaluation of fibrosis in renal biopsies. J Am Soc Nephrol (2010) 2.32
Whole-slide imaging digital pathology as a platform for teleconsultation: a pilot study using paired subspecialist correlations. Arch Pathol Lab Med (2009) 2.30
Early outcomes among those initiating chronic dialysis in the United States. Clin J Am Soc Nephrol (2011) 2.17
Globotriaosylceramide accumulation in the Fabry kidney is cleared from multiple cell types after enzyme replacement therapy. Kidney Int (2002) 2.15
Pros and cons for C4d as a biomarker. Kidney Int (2012) 2.03
National conference to assess antibody-mediated rejection in solid organ transplantation. Am J Transplant (2004) 2.01
Host alloreactive memory T cells influence tolerance to kidney allografts in nonhuman primates. Sci Transl Med (2011) 1.97
Donor Toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantation. Proc Natl Acad Sci U S A (2009) 1.95
Diagnosis of IgG4-related tubulointerstitial nephritis. J Am Soc Nephrol (2011) 1.92
Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification. J Am Soc Nephrol (2002) 1.84
Thrombophilia associated with anti-CD154 monoclonal antibody treatment and its prophylaxis in nonhuman primates. Transplantation (2004) 1.82
Thrombotic microangiopathic glomerulopathy in human decay accelerating factor-transgenic swine-to-baboon kidney xenografts. J Am Soc Nephrol (2005) 1.79
A pathophysiologic role for T lymphocytes in murine acute cisplatin nephrotoxicity. J Am Soc Nephrol (2006) 1.77
Induction of kidney allograft tolerance after transient lymphohematopoietic chimerism in patients with multiple myeloma and end-stage renal disease. Transplantation (2002) 1.75
Overlapping pathways to transplant glomerulopathy: chronic humoral rejection, hepatitis C infection, and thrombotic microangiopathy. Kidney Int (2011) 1.73
Prevalence of renal cell carcinoma in patients with ESRD pre-transplantation: a pathologic analysis. Kidney Int (2002) 1.72
Development of focal segmental glomerulosclerosis after anabolic steroid abuse. J Am Soc Nephrol (2009) 1.70
Autoimmune pancreatitis: a systemic immune complex mediated disease. Am J Surg Pathol (2006) 1.62
NK cells can trigger allograft vasculopathy: the role of hybrid resistance in solid organ allografts. J Immunol (2005) 1.58
Significance of anticardiolipin antibodies on short and long term allograft survival and function following kidney transplantation. Am J Transplant (2004) 1.54
Pseudotumors due to IgG4 immune-complex tubulointerstitial nephritis associated with autoimmune pancreatocentric disease. Am J Surg Pathol (2007) 1.53
Reproduction and transplantation: report on the AST Consensus Conference on Reproductive Issues and Transplantation. Am J Transplant (2005) 1.52
Phenotypic and functional characterization of kidney-infiltrating lymphocytes in renal ischemia reperfusion injury. J Immunol (2006) 1.50
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 36-2003. A 68-year-old woman with impaired renal function. N Engl J Med (2003) 1.47
Xenogeneic thymus transplantation in a pig-to-baboon model. Transplantation (2003) 1.47
Renal interstitial fibrosis: mechanisms and evaluation. Curr Opin Nephrol Hypertens (2012) 1.46
Kidney transplantation: mechanisms of rejection and acceptance. Annu Rev Pathol (2008) 1.46
Pathology after eculizumab in dense deposit disease and C3 GN. J Am Soc Nephrol (2012) 1.43
A prospective, randomized clinical trial of cyclosporine reduction in stable patients greater than 12 months after renal transplantation. Transplantation (2003) 1.41
Penis Transplantation: First US Experience. Ann Surg (2017) 1.38
Thrombotic microangiopathy associated with humoral rejection of cardiac xenografts from alpha1,3-galactosyltransferase gene-knockout pigs in baboons. Am J Pathol (2008) 1.36
Mixed chimerism, lymphocyte recovery, and evidence for early donor-specific unresponsiveness in patients receiving combined kidney and bone marrow transplantation to induce tolerance. Transplantation (2010) 1.25
Early acceptance of renal allografts in mice is dependent on foxp3(+) cells. Am J Pathol (2011) 1.23
A prospective, randomized, clinical trial of intraoperative versus postoperative Thymoglobulin in adult cadaveric renal transplant recipients. Transplantation (2003) 1.19
Prevalence and significance of anti-HLA and donor-specific antibodies long-term after renal transplantation. Transpl Int (2005) 1.17
Long-term follow-up of recipients of combined human leukocyte antigen-matched bone marrow and kidney transplantation for multiple myeloma with end-stage renal disease. Transplantation (2011) 1.12
Normal mouse kidneys contain activated and CD3+CD4- CD8- double-negative T lymphocytes with a distinct TCR repertoire. J Leukoc Biol (2008) 1.11
Fidelity and evolution of recurrent FSGS in renal allografts. J Am Soc Nephrol (2008) 1.11
Effect of mixed hematopoietic chimerism on cardiac allograft survival in cynomolgus monkeys. Transplantation (2002) 1.10
Tubular expression of KIM-1 does not predict delayed function after transplantation. J Am Soc Nephrol (2009) 1.10
Chronic humoral rejection of human kidney allografts associates with broad autoantibody responses. Transplantation (2010) 1.10
Humoral rejection of human organ transplants. Springer Semin Immunopathol (2003) 1.10
Chronic allograft nephropathy. Curr Opin Nephrol Hypertens (2005) 1.09
Spontaneous renal allograft acceptance associated with "regulatory" dendritic cells and IDO. J Immunol (2008) 1.07
Regulatory, effector, and cytotoxic T cell profiles in long-term kidney transplant patients. J Am Soc Nephrol (2009) 1.05
The changing role of natural killer cells in solid organ rejection and tolerance. Transplantation (2006) 1.03
Acute humoral rejection in hepatitis C-infected renal transplant recipients receiving antiviral therapy. Am J Transplant (2003) 1.03
Humoral rejection in kidney transplantation: new concepts in diagnosis and treatment. Curr Opin Nephrol Hypertens (2002) 1.02
Xenogeneic thymokidney and thymic tissue transplantation in a pig-to-baboon model: I. Evidence for pig-specific T-cell unresponsiveness. Transplantation (2003) 1.00
GalT-KO pigs: is the cup half empty or half full? Transplantation (2007) 0.99
Further analysis of the T-cell subsets and pathways of murine cardiac allograft rejection. Am J Transplant (2003) 0.96
Biomarkers and surrogate endpoints in renal transplantation: present status and considerations for clinical trial design. Am J Transplant (2004) 0.95
Suppressive regulatory T cell activity is potentiated by glycogen synthase kinase 3{beta} inhibition. J Biol Chem (2010) 0.94
Case records of the Massachusetts General Hospital. Case 12-2007. A 56-year-old woman with renal failure after heart-lung transplantation. N Engl J Med (2007) 0.93
Monitoring antidonor alloantibodies as a predictive assay for renal allograft tolerance/long-term observations in nonhuman primates. Transplantation (2006) 0.91
Coronary artery disease from isolated non-H2-determined incompatibilities in transplanted mouse hearts. Transplantation (2011) 0.91
Hepatitis C virus infection in haemodialysis and kidney transplant patients. Rev Med Virol (2008) 0.91
Comparison of two dosages of thymoglobulin used as a short-course for induction in kidney transplantation. Transpl Int (2006) 0.91
2005 immunosuppressive strategies in kidney transplantation: which role for the calcineurin inhibitors? Transplantation (2005) 0.90
Role of complement and NK cells in antibody mediated rejection. Hum Immunol (2012) 0.89
Pathologic characteristics of transplanted kidney xenografts. J Am Soc Nephrol (2011) 0.89
Diagnostic challenges in chronic antibody-mediated rejection. Nat Rev Nephrol (2012) 0.88
Chronic alloantibody mediated rejection. Semin Immunol (2011) 0.87
A Bridge to Somewhere: 25-day Survival After Pig-to-Baboon Liver Xenotransplantation. Ann Surg (2016) 0.87
Posttransplant lymphoproliferative disorder associated with an Epstein-Barr-related virus in cynomolgus monkeys. Transplantation (2002) 0.87
Adults with Sotos syndrome: review of 21 adults with molecularly confirmed NSD1 alterations, including a detailed case report of the oldest person. Am J Med Genet A (2011) 0.87
Effect of T cells on vascular permeability in early ischemic acute kidney injury in mice. Microvasc Res (2009) 0.86
Hepatitis C, acute humoral rejection, and renal allograft survival. J Am Soc Nephrol (2004) 0.86
Proliferative index using Ki-67 index in reactive mesothelial versus metastatic adenocarcinoma cells in serous fluid. Adv Biomed Res (2012) 0.86
Pathological features of antibody-mediated rejection. Curr Drug Targets Cardiovasc Haematol Disord (2005) 0.85
Persistent rejection of peritubular capillaries and tubules is associated with progressive interstitial fibrosis. Kidney Int (2002) 0.85
Partial therapeutic response to Rituximab for the treatment of chronic alloantibody mediated rejection of kidney allografts. Transpl Immunol (2012) 0.84
Contributions of direct and indirect alloresponses to chronic rejection of kidney allografts in nonhuman primates. J Immunol (2011) 0.83
The SLAM family member CD48 (Slamf2) protects lupus-prone mice from autoimmune nephritis. J Autoimmun (2011) 0.83
Nephrogenic systemic fibrosis: a pathologic study of autopsy cases. Arch Pathol Lab Med (2009) 0.82
Accurate, fast, and convenient measurement of glomerular filtration rate in potential renal transplant donors. Transplantation (2010) 0.81
The effect of 2,3-dihydroxybenzoic acid and tempol in prevention of vancomycin-induced nephrotoxicity in rats. Toxicology (2007) 0.81
Granulomatous interstitial nephritis as a manifestation of Crohn disease. Arch Pathol Lab Med (2014) 0.81
Reproduction and pregnancy in transplant recipients: current practices. Prog Transplant (2006) 0.81
Stem cell mobilization and collection for induction of mixed chimerism and renal allograft tolerance in cynomolgus monkeys. J Surg Res (2010) 0.80
Aerobic exercise improves signs of restless leg syndrome in end stage renal disease patients suffering chronic hemodialysis. ScientificWorldJournal (2013) 0.80
Cyclosporine toxicity in immunosuppressed streptozotocin-diabetic nonhuman primates. Toxicology (2005) 0.79
Mechanisms of chronic renal allograft rejection. II. Progressive allograft glomerulopathy in miniature swine. Lab Invest (2002) 0.79
A comparison of the quality of life of the patients undergoing hemodialysis versus peritoneal dialysis and its correlation to the quality of dialysis. Saudi J Kidney Dis Transpl (2016) 0.78
Transitional cell carcinoma arising within a pediatric donor renal transplant in association with BK nephropathy. Transplantation (2013) 0.78
The Direct Medical Costs of Colorectal Cancer in Iran; Analyzing the Patient's Level Data from a Cancer Specific Hospital in Isfahan. Int J Prev Med (2012) 0.78
Analysis of the cardiovascular risk profile in stable kidney transplant recipients after 50% cyclosporine reduction. Clin Transplant (2004) 0.78
Prognostic value of insulin- like growth factor-I receptor expression in renal cell carcinoma. Saudi J Kidney Dis Transpl (2010) 0.78